Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) announced that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 1:30 p.m. Eastern Time. The presentation will be available via live webcast with a two-week replay on Inspire’s investor website.

Market Context

INSP's recent insider context was labeled Net Selling. Against that backdrop, this scheduled present...

Analysis

INSP's recent insider context was labeled Net Selling. Against that backdrop, this scheduled presentation offered no disclosed operating result; investors could watch for new information, with short positioning remaining a risk factor.

Key Figures

Conference edition: 21st annual Presentation date: September 9, 2026 Presentation time: 1:30 p.m. Eastern Time +1 more

4 metrics

Conference edition 21st annual Wells Fargo Healthcare Conference

Presentation date September 9, 2026 Scheduled conference presentation

Presentation time 1:30 p.m. Eastern Time Scheduled presentation

Replay availability two weeks Following the presentation

Historical Context

5 past events · Latest: Aug 03 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 03	Board appointment	Neutral	+22.8%	Mobia appointed a director who also served on Inspire's board.
Aug 03	Q2 earnings report	Positive	+22.8%	Inspire reported Q2 results and raised 2026 revenue guidance.
Jul 27	Board appointment	Positive	+3.5%	Inspire appointed medical-device executive Michael H. Carrel to its board.
Jul 22	Board retirement	Negative	-4.0%	Director Casey M. Tansey announced retirement after more than 18 years.
Jul 06	Earnings scheduling	Neutral	+5.3%	Inspire corrected the scheduled date for its second-quarter results.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The historical record showed positive company news aligning with gains and negative board news aligning with declines, while neutral scheduling news diverged.

Key Terms

obstructive sleep apnea

1 terms

obstructive sleep apnea medical

"solutions for patients with obstructive sleep apnea"

Obstructive sleep apnea is a common medical condition where the throat repeatedly narrows or closes during sleep, causing short pauses in breathing, drops in blood oxygen and fragmented rest. It matters to investors because it creates ongoing demand for medical devices, diagnostics, treatments and sleep-monitoring services, and it can affect population health, workforce productivity and healthcare spending—like a recurring leak in a system that requires continual repair and monitoring.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 21^st Annual Healthcare Conference on Wednesday, September 9, 2026.

Inspire is scheduled to present at 1:30 p.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Louisa Smith
Principal, Gilmartin Group
IR@inspiresleep.com

FAQ

When will Inspire Medical Systems (NYSE: INSP) present at the Wells Fargo 21st Annual Healthcare Conference?

Inspire Medical Systems will present on Wednesday, September 9, 2026, at 1:30 p.m. Eastern Time. According to Inspire Medical Systems, this session is part of the Wells Fargo 21st Annual Healthcare Conference and will feature the company’s management team.

How can investors listen to the Inspire Medical Systems (INSP) presentation at the Wells Fargo Healthcare Conference 2026?

Investors can listen via a live webcast of Inspire Medical Systems’ presentation. According to Inspire Medical Systems, access is provided online, and the webcast link will allow real-time audio of the management team’s conference session.

Will a replay of the Inspire Medical Systems (INSP) Wells Fargo conference presentation be available?

Yes, a replay will be available for two weeks after the presentation. According to Inspire Medical Systems, the webcast replay can be found in the Event Archive section of the company’s investor website at investors.inspiresleep.com.

Where will the Inspire Medical Systems (INSP) Wells Fargo conference replay be hosted for investors?

The replay will be hosted in the Event Archive section of Inspire Medical Systems’ investor website. According to Inspire Medical Systems, investors can visit https://investors.inspiresleep.com to access the archived webcast for two weeks following the event.

What type of company is Inspire Medical Systems (NYSE: INSP) presenting at the Wells Fargo 21st Annual Healthcare Conference?

Inspire Medical Systems is a medical technology company focused on minimally invasive solutions for obstructive sleep apnea. According to Inspire Medical Systems, it develops and commercializes innovative therapies designed to treat patients with this sleep-related breathing disorder.